Acne Clinical Trial
Official title:
Phase 2 Study of the Efficacy and Safety of 3% Povidone-Iodine in Acne Therapy
Importance This will be a proof of concept study - whereby we hypothesize that Repigel may
represent a paradigm shift in global acne treatment.
Historically, there has been a dearth of clinical evidence in this use of povidone-iodine
for inflammatory acne. This is likely due to staining related to iodine use, which is not
acceptable to consumers.
The trial drug, Povidone Iodine, however, becomes colourless and odourless in a matter of
seconds after application on the skin.
This represents an ideal product for which we may perform testing to look at its efficacy in
the management of acne.
A mainstay in the pathogenesis of acne involves the overgrowth and proliferation of skin
micro-organisms, primarily proprionibacterium Acnes. Long term antibiotic therapy is usually
prescribed for a period of 3 to 6 months or more.
Previous studies have revealed this form of antibiotic therapy is ineffective, patients are
usually poorly compliant, and also results in the formation of antibiotic resistant
micro-organisms,which in turn reduces treatment efficacy.
Potential Benefits
As such, Povidone Iodine with its antiseptic property represents a promising avenue for the
elimination of Proprionibacterium Acnes without the associated problems of long term
antibiotic use, and the development of antibiotic-resistance. It is cosmetically acceptable,
affordable, and easy to use.
Aim This is a proof of concept study - to determine the efficacy and safety of Povidone
Iodine in the treatment of acne.
Methodology This will be a single centre, double blind, randomized controlled trial. There
will be 2 arms of 15 patients with a 2 month study period.
Follow up at Week 0, Week 2, Week 4, Week 6, Week 8
3. Capture baseline demographics
a. Age b. Sex c. Race d. Lesion counts - total, inflammatory, non-inflammatory e. FDA score
4. Efficacy evaluation
a. 5 point IGA score b. Total lesional count c. No. of inflammatory lesions d. No. of
non-inflammatory lesions e. Photography (+-) f. Scoring of the Cardiff Acne Disability
Index.
5. Safety Evaluation
a. Score of itchiness b. Score of scaling c. Score of erythema d. Score of pain
6. Primary end points -
a. percentage reduction in lesion counts from week 0 to week 8 i. total lesion counts ii.
total inflammatory counts iii. total non-inflammatory counts b. Proportion of subjects who
had a IGA score of 0 or 1 by week 8 c. Time to 50% reduction of total lesion counts
7. Secondary end point
a. Improvement of the Cardiff Acne Disability Index
Povidone Iodine will be applied on the face by the patient using his own finger tips - onto
his acne affected areas on the face.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05097157 -
Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions
|
N/A | |
Completed |
NCT05131373 -
Safety, Tolerability, and Immunogenicity of ORI-A-ce001 for the Treatment of Acne Vulgaris
|
Phase 1 | |
Completed |
NCT04806594 -
Clinical Investigation on the Safety and Clinical Performance of Papix Acne Scar.
|
N/A | |
Recruiting |
NCT03465150 -
Creation of a Monocentric Cohort of Patients Treated for Acne at the Nantes University Hospital
|
||
Completed |
NCT02250859 -
A Pharmacokinetic Study of Minocycline in Male and Female Volunteers
|
Phase 1 | |
Terminated |
NCT01193764 -
Study Assessing the Effect of Chocolate Consumption in Subjects With A History of Acne Vulgaris
|
N/A | |
Completed |
NCT01206348 -
Combination Treatment for Moderate to Severe Acne
|
Phase 4 | |
Completed |
NCT00725439 -
An Open Label Trial to Assess the Safety and Efficacy of Oral R115866 in the Treatment Facial Acne
|
Phase 2 | |
Completed |
NCT05640388 -
Assessment of a Cosmetic Product Effect on the Host/Microorganism Relationship in Acneic Subjects
|
||
Completed |
NCT04873089 -
Efficacy Study of Cosmetic Product RV3278AET0943 Versus Non-treated Group in Adults With Oily and Acne Prone Skin
|
||
Recruiting |
NCT05941065 -
Study of Skin Balancing Gel Cream Safety and Influence of Skin Microbiome on Acne Prone Skin
|
N/A | |
Recruiting |
NCT06120452 -
A Clinical Trial to Evaluate the Effectiveness of an Acne Serum in Improving Facial Acne and Post-Acne Pigmentation
|
N/A | |
Completed |
NCT04300010 -
Blue Light Therapy of C. Acnes
|
Phase 4 | |
Recruiting |
NCT06202274 -
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
|
N/A | |
Completed |
NCT04559022 -
Pilot Study Investigating the Efficacy of Fat Grafting as a Treatment for Male and Female Facial Acne Scarring
|
N/A | |
Terminated |
NCT02431494 -
Safety and Preliminary Efficacy of Combination Therapy for the Treatment of Acne Vulgaris
|
N/A | |
Completed |
NCT05469880 -
Efficacy and Tolerance of Formula 609613 37 in Acneic Patients
|
N/A | |
Completed |
NCT02944461 -
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
|
Phase 4 | |
Completed |
NCT01951417 -
Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris
|
Phase 4 | |
Completed |
NCT01701024 -
Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne
|
Phase 3 |